BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22031844)

  • 1. Recent perspectives into biochemistry of decavanadate.
    Aureliano M
    World J Biol Chem; 2011 Oct; 2(10):215-25. PubMed ID: 22031844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances into vanadyl, vanadate and decavanadate interactions with actin.
    Ramos S; Moura JJ; Aureliano M
    Metallomics; 2012 Jan; 4(1):16-22. PubMed ID: 22012168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decavanadate, decaniobate, tungstate and molybdate interactions with sarcoplasmic reticulum Ca(2+)-ATPase: quercetin prevents cysteine oxidation by vanadate but does not reverse ATPase inhibition.
    Fraqueza G; Batista de Carvalho LA; Marques MP; Maia L; Ohlin CA; Casey WH; Aureliano M
    Dalton Trans; 2012 Nov; 41(41):12749-58. PubMed ID: 22968713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcoplasmic reticulum calcium ATPase interactions with decaniobate, decavanadate, vanadate, tungstate and molybdate.
    Fraqueza G; Ohlin CA; Casey WH; Aureliano M
    J Inorg Biochem; 2012 Feb; 107(1):82-9. PubMed ID: 22178669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decavanadate interactions with actin: cysteine oxidation and vanadyl formation.
    Ramos S; Duarte RO; Moura JJ; Aureliano M
    Dalton Trans; 2009 Oct; (38):7985-94. PubMed ID: 19771361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decavanadate induces mitochondrial membrane depolarization and inhibits oxygen consumption.
    Soares SS; Gutiérrez-Merino C; Aureliano M
    J Inorg Biochem; 2007 May; 101(5):789-96. PubMed ID: 17349695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actin as a potential target for decavanadate.
    Ramos S; Moura JJ; Aureliano M
    J Inorg Biochem; 2010 Dec; 104(12):1234-9. PubMed ID: 20807665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decavanadate (V10 O28 6-) and oxovanadates: oxometalates with many biological activities.
    Aureliano M; Crans DC
    J Inorg Biochem; 2009 Apr; 103(4):536-46. PubMed ID: 19110314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decavanadate effects in biological systems.
    Aureliano M; Gândara RM
    J Inorg Biochem; 2005 May; 99(5):979-85. PubMed ID: 15833319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decavanadate interactions with actin: inhibition of G-actin polymerization and stabilization of decameric vanadate.
    Ramos S; Manuel M; Tiago T; Duarte R; Martins J; Gutiérrez-Merino C; Moura JJ; Aureliano M
    J Inorg Biochem; 2006 Nov; 100(11):1734-43. PubMed ID: 16890293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanadium distribution, lipid peroxidation and oxidative stress markers upon decavanadate in vivo administration.
    Soares SS; Martins H; Duarte RO; Moura JJ; Coucelo J; Gutiérrez-Merino C; Aureliano M
    J Inorg Biochem; 2007 Jan; 101(1):80-8. PubMed ID: 17030392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanadate induces necrotic death in neonatal rat cardiomyocytes through mitochondrial membrane depolarization.
    Soares SS; Henao F; Aureliano M; Gutiérrez-Merino C
    Chem Res Toxicol; 2008 Mar; 21(3):607-18. PubMed ID: 18251508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decavanadate Toxicology and Pharmacological Activities: V10 or V1, Both or None?
    Aureliano M
    Oxid Med Cell Longev; 2016; 2016():6103457. PubMed ID: 26904166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of vanadate oligomers with sarcoplasmic reticulum Ca(2+)-ATPase.
    Aureliano M; Mdeira VM
    Biochim Biophys Acta; 1994 Apr; 1221(3):259-71. PubMed ID: 8167147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanadate oligomers: in vivo effects in hepatic vanadium accumulation and stress markers.
    Gândara RM; Soares SS; Martins H; Gutiérrez-Merino C; Aureliano M
    J Inorg Biochem; 2005 May; 99(5):1238-44. PubMed ID: 15833347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in toadfish (Halobactrachus didactylus) cardiac muscle. Acute exposure to vanadate oligomers.
    Aureliano M; Joaquim N; Sousa A; Martins H; Coucelo JM
    J Inorg Biochem; 2002 Jun; 90(3-4):159-65. PubMed ID: 12031809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decavanadate as a biochemical tool in the elucidation of muscle contraction regulation.
    Tiago T; Aureliano M; Moura JJ
    J Inorg Biochem; 2004 Nov; 98(11):1902-10. PubMed ID: 15522416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanadate oligomer interactions with myosin.
    Aureliano M
    J Inorg Biochem; 2000 May; 80(1-2):141-3. PubMed ID: 10885475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vanadium distribution following decavanadate administration.
    Soares SS; Martins H; Aureliano M
    Arch Environ Contam Toxicol; 2006 Jan; 50(1):60-4. PubMed ID: 16151690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decavanadate in vitro and in vivo effects: facts and opinions.
    Aureliano M; Ohlin CA
    J Inorg Biochem; 2014 Aug; 137():123-30. PubMed ID: 24865633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.